AI Research
Causaly Introduces First Agentic AI Platform Built for Life Sciences Research and Development
Specialized AI agents automate research workflows and accelerate
drug discovery and development with transparent, evidence-backed insights
LONDON, Sept. 16, 2025 /PRNewswire/ — Causaly today introduced Causaly Agentic Research, an agentic AI breakthrough that delivers the transparency and scientific rigor that life sciences research and development demands. First-of-their-kind, specialized AI agents access, analyze, and synthesize comprehensive internal and external biomedical knowledge and competitive intelligence. Scientists can now automate complex tasks and workflows to scale R&D operations, discover novel insights, and drive faster decisions with confidence, precision, and clarity.
Industry-specific scientific AI agents
Causaly Agentic Research builds on Causaly Deep Research with a conversational interface that lets users interact directly with Causaly AI research agents. Unlike legacy literature review tools and general-purpose AI tools, Causaly Agentic Research uses industry-specific AI agents built for life sciences R&D and securely combines internal and external data to create a single source of truth for research. Causaly AI agents complete multi-step tasks across drug discovery and development, from generating and testing hypotheses to producing structured, transparent results always backed by evidence.
“Agentic AI fundamentally changes how life sciences conducts research,” said Yiannis Kiachopoulos, co-founder and CEO of Causaly. “Causaly Agentic Research emulates the scientific process, automatically analyzing data, finding biological relationships, and reasoning through problems. AI agents work like digital assistants, eliminating manual tasks and dependencies on other teams, so scientists can access more diverse evidence sources, de-risk decision-making, and focus on higher-value work.”
Solving critical research challenges
Research and development teams need access to vast amounts of biomedical data, but manual and siloed processes slow research and create long cycle times for getting treatments to market. Scientists spend weeks analyzing narrow slices of data while critical insights remain hidden. Human biases influence decisions, and the volume of scientific information overwhelms traditional research approaches.
Causaly addresses these challenges as the first agentic AI platform for scientists that combines extensive biomedical information with competitive intelligence and proprietary datasets. With a single, intelligent interface for scientific discovery that fits within scientists’ existing workflows, research and development teams can eliminate silos, improve productivity, and accelerate scientific ideas to market.
Comprehensive agentic AI research platform
As part of the Causaly platform, Causaly Agentic Research provides scientists multiple AI agents that collaborate to:
- Conduct complex analysis and provide answers that move research forward
- Verify quality and accuracy to dramatically reduce time-to-discovery
- Continuously scan the scientific landscape to surface critical signals and emerging evidence in real time
- Deliver fully traceable insights that help teams make confident, evidence-backed decisions while maintaining scientific rigor for regulatory approval
- Connect seamlessly with internal systems, public applications, data sources, and even other AI agents, unifying scientific discovery
Availability
Causaly Agentic Research will be available in October 2025, with a conversational interface and foundational AI agents to accelerate drug discovery and development. Additional specialized AI agents are planned for availability by the end of the year.
Explore how Causaly Agentic Research can redefine your R&D workflows and bring the future of drug development to your organization at causaly.com/products/agentic-research.
About Causaly
Causaly is a leader in AI for the life sciences industry. Leading biopharmaceutical companies use the Causaly AI platform to find, visualize, and interpret biomedical knowledge and automate critical research workflows. To learn how Causaly is accelerating drug discovery through transformative AI technologies and getting critical treatments to patients faster, visit www.causaly.com.
Logo – https://mma.prnewswire.com/media/2653240/Causaly_Logo_Logo.jpg
AI Research
OpenAI reveals how most people are using ChatGPT | Science, Climate & Tech News

Most people are using ChatGPT to ask questions and get advice, new data from OpenAI revealed.
Although AI bots can do anything from coding to drafting emails or even playing, around 49% of the requests sent to ChatGPT since November 2022 were people asking the bot questions and looking for information, a report by the National Bureau of Economic Research (NBER) and OpenAI found.
It’s the biggest study of its kind and draws from the huge amount of data collected by OpenAI – around 10% of the world’s population is now thought to use the AI tool.
Although there was a steady growth in people using ChatGPT for work-related queries, more than 70% of all usage was non-work related, according to the report.
There’s also been a shift in who is using AI tools.
Early adopters of AI tended to be men, with around 80% of weekly users having typically masculine first names in the months after ChatGPT was released.
By June 2025, however, users were more likely to have typically female first names, something the authors described as a “dramatic shift”.
Anthropic AI, which runs the Claude AI chatbot, also released its own data on how customers are using AI.
It found that the use of AI strongly correlated with average incomes.
More affluent nations like Singapore and Canada were at the top end of countries using AI, while emerging economies like Indonesia, India and Nigeria, used Claude less.
In the US, economic differences even played out at state level, and Claude researchers found that adoption of the technology rose faster with income.
Read more from Sky News:
PM’s ‘AI superpower’ dream at risk, industry warns
Zelenskyy makes demand of Trump
Trump sues New York Times
Each 1% increase in state GDP was associated with a 1.8% increase in usage of AI.
Usage also reflected what those areas were best known for; in California, Claude was often used to help with IT problems, in Florida, it was used for financial services and in Washington DC it was used for document editing and career assistance.
AI literacy consultant Sarah J Lundrigan posted about the two reports, saying the “blunt truth” is: “If you’re still treating AI as ‘something to try later,’ you’re behind.
“The value isn’t in futuristic features – it’s in solving today’s friction points.
“The winners will be the ones who can simplify adoption, reduce overwhelm, and make AI part of how people work and live.”
AI Research
5 ways AI is shaping packaging today
In Nestlé’s R&D department, a tool is identifying entirely new kinds of high-barrier packaging materials. It’s generative AI.
A growing number of consumer packaged goods companies are starting to deploy artificial intelligence in their packaging design processes. So too are packaging manufacturers exploring how the technology can save time and resources in design and manufacturing.
Nestlé’s researchers feed public and proprietary documents into a knowledge base. Then, they fine-tune the data using a transformer, together with IBM Research, to understand how molecular features in packaging correlate to physical properties. Finally, the AI-based model analyzes the inputs within the set parameters.
“It can identify appropriate materials that are suitable for protecting dry and sensitive foods such as coffee from moisture, temperature swings and oxygen,” a Nestlé spokesperson said via email.
While the use cases are nascent, AI is catching on. Last year, a McKinsey survey of more than 200 paper and packaging executives found that 95% said they believe their companies should invest in generative AI. And 77% said their firms have moderate to strong intentions to use gen AI in the near future.
How packaging leaders and CPGs are using AI
Tom Egan, vice president of industry services for the Association for Packaging and Processing Technologies, or PMMI, sees “a pretty enthusiastic acceptance” of AI in the industry. He said applications range from logistics to sales and marketing to manufacturing.
Here are some of the processes in which packaging companies and CPGs are starting to use AI.
New designs and prototypes
One of the notable potential benefits of AI — and among the biggest use cases being explored today — is the ability to assess packaging modifications or updates in a virtual environment.
When a client requests a new design from flexible packaging provider Tradepak, the company inputs the customer’s parameters into its systems, said President Rafael Recao. AI can rapidly pull from databases, synthesize data points, and deliver design and substrate recommendations. Then, packaging leaders make a final decision.
With simulation models and digital twins, AI can look at form factors, examine touch points and predict consumer reactions to quickly generate 10 mockups of a SKU’s packaging, Egan said, rather than physically making and testing each version.
AI can “analyze this unbelievably large number of data points and provide you with insights,” Egan said, adding that packaging leaders can refine the options from there.
Simulation models can also help to design packaging for the same product in different channels, such as one version for retail shelves and another for e-commerce. AI could determine the best design and protective properties for each channel while ensuring brand consistency, Egan said.
Simulating testing
Colgate-Palmolive is exploring how simulations could validate new designs for components such as bottles, caps and spray pumps, said Sukhdev Singh Saini, global toothbrush and devices packaging lead at the company.
Without AI, “we have to physically make a lot of samples to test,” Saini said. Then, the samples have to be shipped, tested and possibly altered before being sent out for another round of testing. “There is a lot of time involved, a lot of material involved.”
With a simulation model, though, the CPG feeds specs into a system, and AI replicates testing to provide results. Saini acknowledged the tech is still a work in progress and not a 100% replacement just yet.
Jonathan Garini, CEO and enterprise AI consultant at Fifthelement, sees brands using algorithms to simulate how a substrate performs in real-life conditions like humidity or rough handling.
“This not only accelerates the test cycle but also can lower the cost of physical prototyping significantly,” Garini said.
Packaging artwork
Recao said Tradepak uses Adobe Illustrator equipped with AI to make adjustments on colors, design placement and other elements before printing.
For artwork, Colgate-Palmolive works with Esko software, which uses automation throughout the packaging go-to-market process. The use of AI in artwork management has improved quality while saving time, Saini said.
Without the system, the CPG would have to individually search previous artwork details to make even minor modifications. But now, the person who manages artwork can receive data in minutes and make decisions more efficiently. In a major run of 50 or more SKUs, Saini said Colgate-Palmolive has cut down the development time by 60% to 70%.
Assessing recyclability
Colgate-Palmolive has partnered with Glacier on an AI-based system for sorting toothpaste tubes at recycling facilities. The CPG can view a dashboard that shows toothpaste tube materials and their recyclability, along with tube recycling behavior in various cities.
With more states adopting extended producer responsibility programs, Saini anticipates “a lot of work being done on recyclability.”
Another generative AI use case that McKinsey noted in its report is to enhance visual inspection systems for waste, in order to improve the quality of recycled paper and cardboard.
Manufacturing, production and maintenance
Many CPGs use computer vision, optical systems and imaging technology on production lines. It’s not a new phenomenon, but machine learning is “taking it a couple of notches up” with AI-based features that improve quality management systems, Saini said.
At Nestlé, high-resolution imaging technology monitors lines for quality assurance.
“Through machine learning, these technologies can anticipate issues on the production line, and provide appropriate recommendations, such as preventative maintenance or cleaning,” Nestlé’s spokesperson said.
Recao uses augmented reality glasses to connect with manufacturing facilities in Europe so Tradepak can monitor any equipment issue in real time.
“We save a lot of time,” Recao said. “We resolve the problem quickly.”
What’s next with AI in packaging
It’s still early days for AI in packaging, and many areas remain untapped to their fullest potential. Garini sees AI being used to predict how consumers perceive packaging, and how that affects sales, including the use of packaging as a communication tool.
“Models now are being trained to predict how form factor, texture and color all play roles in shelf appeal and online conversion,” Garini said.
There are also some barriers to adoption.
Implementing new technology requires change management and for employees to embrace and trust the system. Cybersecurity could be a concern with AI models receiving proprietary data, and software subscriptions can be expensive, Recao noted.
AI outputs are only as good as their inputs, which means organizations need a solid foundation of data, Egan said. In fact, McKinsey’s survey found that limited access to a modern data tech stack was the top limitation in AI implementations.
But CPGs and packaging manufacturers remain bullish on AI’s potential.
Nestlé envisions its technology will help to scale packaging solutions across more categories. Saini believes the tools Colgate-Palmolive uses will save resources and improve recyclability. Recao said there’s always more advanced AI that can apply to robotics and machinery.
“Right now, the potential of AI in our industry is enormous,” Recao said. “The sky is the limit.”
AI Research
State AGs’ Continued Focus on Enforcement – With or Without AI Legislation — The Good Bot: Artificial Intelligence, Health Care, and the Law | Troutman Pepper Locke

In this episode of The Good Bot, Brett Mason is joined by Gene Fishel and Chris Carlson to discuss the latest state laws targeting AI, especially in health care. They break down new legislation in Colorado, Utah, California, and Texas, highlighting differences in scope and enforcement. They also cover how state attorneys general are using consumer protection and anti-discrimination laws to regulate AI, even in states without AI-specific statutes.
Press CTRL+C to copy embed code to clipboard
-
Business3 weeks ago
The Guardian view on Trump and the Fed: independence is no substitute for accountability | Editorial
-
Tools & Platforms1 month ago
Building Trust in Military AI Starts with Opening the Black Box – War on the Rocks
-
Ethics & Policy2 months ago
SDAIA Supports Saudi Arabia’s Leadership in Shaping Global AI Ethics, Policy, and Research – وكالة الأنباء السعودية
-
Events & Conferences4 months ago
Journey to 1000 models: Scaling Instagram’s recommendation system
-
Jobs & Careers3 months ago
Mumbai-based Perplexity Alternative Has 60k+ Users Without Funding
-
Podcasts & Talks2 months ago
Happy 4th of July! 🎆 Made with Veo 3 in Gemini
-
Education3 months ago
VEX Robotics launches AI-powered classroom robotics system
-
Education2 months ago
Macron says UK and France have duty to tackle illegal migration ‘with humanity, solidarity and firmness’ – UK politics live | Politics
-
Podcasts & Talks2 months ago
OpenAI 🤝 @teamganassi
-
Funding & Business3 months ago
Kayak and Expedia race to build AI travel agents that turn social posts into itineraries